Tech Company Financing Transactions

ViroCell Biologics Funding Round

On 8/15/2024, ViroCell Biologics landed investment from First Light Asset Management.

Transaction Overview

Company Name
Announced On
8/15/2024
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its growth, as it continues to gain commercial traction with its specialist services in viral vector design and manufacturing.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
12-18 Theobalds Road
London, WC1X 8SL
UK
Email Address
Overview
ViroCell Biologics is an innovation-driven CDMO focused exclusively on the design and GMP manufacture of lentiviral and gamma-retro viral vectors to enable novel cell and gene therapies to enter clinical trials. By leveraging Team ViroCell's 20+ year track record of manufacturing ~200 vectors, we are driven to accelerate the development of much-needed therapies so that disease can recede and progress can prevail.
Profile
ViroCell Biologics LinkedIn Company Profile
Social Media
ViroCell Biologics Company Twitter Account
Company News
ViroCell Biologics News
Facebook
ViroCell Biologics on Facebook
YouTube
ViroCell Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Hadden
  John Hadden LinkedIn Profile  John Hadden Twitter Account  John Hadden News  John Hadden on Facebook
Chief Financial Officer
Brian Collins
  Brian Collins LinkedIn Profile  Brian Collins Twitter Account  Brian Collins News  Brian Collins on Facebook
Chief Information Officer
James Ainsworth
  James Ainsworth LinkedIn Profile  James Ainsworth Twitter Account  James Ainsworth News  James Ainsworth on Facebook
Chief Scientific Officer
Farzin Farzaneh
  Farzin Farzaneh LinkedIn Profile  Farzin Farzaneh Twitter Account  Farzin Farzaneh News  Farzin Farzaneh on Facebook
Vice President
Clare Millar
  Clare Millar LinkedIn Profile  Clare Millar Twitter Account  Clare Millar News  Clare Millar on Facebook
VP - Bus. Development
Traci Kyes
  Traci Kyes LinkedIn Profile  Traci Kyes Twitter Account  Traci Kyes News  Traci Kyes on Facebook
VP - Bus. Development
Makis Sigalas
  Makis Sigalas LinkedIn Profile  Makis Sigalas Twitter Account  Makis Sigalas News  Makis Sigalas on Facebook
VP - General Counsel
Jason Tang
  Jason Tang LinkedIn Profile  Jason Tang Twitter Account  Jason Tang News  Jason Tang on Facebook
VP - Human Resources
Toni Trevett
  Toni Trevett LinkedIn Profile  Toni Trevett Twitter Account  Toni Trevett News  Toni Trevett on Facebook
VP - Manufacturing
Gaik Kee
  Gaik Kee LinkedIn Profile  Gaik Kee Twitter Account  Gaik Kee News  Gaik Kee on Facebook
VP - Regulatory Affairs
Rita Rego
  Rita Rego LinkedIn Profile  Rita Rego Twitter Account  Rita Rego News  Rita Rego on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/15/2024: Rx Save Card venture capital transaction
Next: 8/15/2024: Boosted.ai venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary